LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: INTERIM RESULTS OF THE ONGOING PHASE 2 OPEN-LABEL EXTENSION STUDY

Marc Ferrante  1     Julian Panés  2     Filip Baert  3     Edouard Louis  4     Arthur Kaser  5     Dawn Gustafson  6     David Hall  7     Wulf O. Böcher     Ivona Herichova     Xiaomei Liao     Kori Wallace     Jasmina Kalabic     Geert R. D'Haens    
1 University Hospitals Leuven,Leuven,Belgium
2 Hospital Clínic Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 AZ Delta Roeselare-Menen,Roeselare,Belgium
4 University of Liège and CHU,Liège,Belgium
5 University of Cambridge,Cambridge,United Kingdom
6 AbbVie Inc.,North Chicago,United States
7 Boehringer Ingelheim International GmbH,Ingelheim a

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing